Proa Medical Receives Positive Reception for Brella Vaginal Retractor at Mexican Congress of Gynecology and Obstetrics

Proa® Medical, Inc., developer of innovative and practical medical devices for women’s health, today announced that the company received significant positive feedback for its FDA-cleared Brella® Vaginal Retractor at the recent 64° Congreso Mexicano de Ginecología y Obstetricia, the largest U.S. congress for women’s health, held in Mexico City.

The Brella® Vaginal Retractor is a single-use retractor with a built-in light source designed to provide optimal visualization and access during repair of the vaginal walls and perineum. Proa Medical is exploring opportunities to distribute the product throughout Mexico.

“Proa Medical received a very favorable response to the Brella Vaginal Retractor from physicians and hospitals at the Mexican Congress of Gynecology and Obstetrics,” said Afshin Nadershahi, MD, Chief Technology Officer of Proa Medical. “That demonstrated to us that there is a large global market that could benefit from our devices. Physicians and hospitals were interested in the improved outcomes and time savings that could be delivered by our products.”

“Proa Medical’s devices can improve some of the most commonly-performed medical procedures in the world,” said Arman Nadershahi, Chief Executive Officer of Proa Medical. “Because of this, we are seeking distribution partners in important markets globally that can bring our portfolio of innovative women’s health devices to physicians in order to better serve their patients.”